Japan Vows Anew To Overcome Reluctance To Boost Generics Use
This article was originally published in PharmAsia News
Executive Summary
Despite slow adoption, the potential for massive shift in Japan’s branded-generics market is a draw for foreign firms as policymakers see increased usage as key to containing health costs.
You may also be interested in...
MHLW Reports Little Progress In Japan’s Generic Drug Use
Ministry of Health Labor and Welfare Minister Yoichiro Masuzoe and Treasury Minister Shoichi Nakagawa Dec. 18 announced a plan of reducing ¥220 billion in social insurance growth for fiscal year 2009, in which the real reduction will come from ¥23 billion as a result of generic drug use. However, a report released Dec. 15 by MHLW painted a discouraging picture of generic drug use in Japan, even amidst several pushes from the ministry to promote usage during the year.
Generic Drug Makers Preparing To Make Japanese Utilization Goal A Reality
TOKYO - The Japan Generic Medicines Association released survey results July 9 saying its 40 member companies are gearing up to manufacture considerably more generics in the next few years. Generic drug makers say they are meeting expectations set by the Ministry of Health, Labour and Welfare to raise Japan's generic drug use share for prescriptions from the current 17 percent to the government goal of 30 percent by fiscal year 2012